Skip to main content

Table 1 Genomic analysis (FoundationOne CDx) of recurrent tumors in the colon (China Medical University Hospital)

From: Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report

Finding Result
Biomarkers
 Microsatellite status (MS) Stable
 Tumor mutational burden (TMB) Low
Genomic data
ARID1A M1154fs*7, Y788*
ERBB2 Amplification
APC G2400*
GABRA6 K110T
TERT promoter 124C > 7
TP53 R280K